Drugs / Autologous tumor cells plus dendritic cells
Autologous tumor cells plus dendritic cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00948480 | Oct 2000 → Sep 2007 | metastatic melanoma | Hoag Memorial Hospital Presbyterian | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous tumor cells plus dendritic cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00948480 ↗ |
| Modality | Vaccine | “patient-specific antitumor vaccines” PMID 19538053 ↗ Jun 2009 |
| Route | Subcutaneous | “received subcutaneous (s.c.) injections of irradiated autologous tumor cells that had been established as short-term cell lines, in conjunction with their own dendritic cells” NCT00948480 ↗ |